Standard Biotools Inc. SEC filings LAB
Standard Biotools Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jun 30, 2016. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 5, 2026 | Nov 5, 2026 |
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 425 | Filing | Nov 3, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 3, 2026 | Nov 3, 2026 |
| 424B3 | Prospectus | Oct 30, 2026 | — |
| EFFECT | Filing | Oct 21, 2026 | — |
| 424B3 | Prospectus | Oct 21, 2026 | — |
| S-4/A | Filing | Oct 21, 2026 | — |
| S-4/A | Filing | Oct 9, 2026 | — |
| 425 | Filing | Oct 5, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 5, 2026 | Oct 5, 2026 |
| 425 | Filing | Sep 30, 2026 | — |
| 8-K |
Current report
Material agreement, Agreement ended, Regulation FD disclosure
|
Sep 30, 2026 | Sep 30, 2026 |
| S-4/A | Filing | Sep 9, 2026 | — |
| 4 | Insider transaction | Aug 24, 2026 | Aug 20, 2026 |
| 4 | Insider transaction | Aug 24, 2026 | Aug 20, 2026 |
| 4 | Insider transaction | Aug 24, 2026 | Aug 20, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| S-8 | Employee stock plan registration | Aug 5, 2026 | — |
| S-8 | Employee stock plan registration | Aug 5, 2026 | — |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2026 | Aug 5, 2026 |
| 4 | Insider transaction | Aug 4, 2026 | Aug 3, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 30, 2026 | — |
| 425 | Filing | Jul 29, 2026 | — |
| 8-K/A | Amended current report | Jul 29, 2026 | Jul 28, 2026 |
| 425 | Filing | Jul 28, 2026 | — |
| 425 | Filing | Jul 28, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 28, 2026 | Jul 24, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Listing notice
|
Jul 24, 2026 | Jul 22, 2026 |
| 425 | Filing | Jul 20, 2026 | — |
| S-4 | Registration for a merger or exchange | Jul 20, 2026 | — |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 20, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 18, 2026 | Jun 17, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Jun 12, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 9, 2026 | — |
| 425 | Filing | Jun 8, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Regulation FD disclosure
|
Jun 8, 2026 | Jun 6, 2026 |
| 8-K |
Current report
Other events
|
Jun 5, 2026 | Jun 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 3, 2026 | May 29, 2026 |
| SD | Specialized disclosure (conflict minerals) | May 29, 2026 | — |
| 8-K |
Current report
Officer or director change
|
May 28, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 5, 2026 | May 5, 2026 |
| ARS | Annual report to shareholders | Apr 27, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Listing notice
|
Apr 24, 2026 | Sep 13, 2025 |
| 4 | Insider transaction | Apr 8, 2026 | Mar 20, 2026 |
| 4 | Insider transaction | Apr 8, 2026 | Mar 20, 2026 |
| 4 | Insider transaction | Apr 8, 2026 | Mar 20, 2026 |
| 10-K | Annual report | Mar 16, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 23, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 23, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 23, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 24, 2026 | Feb 24, 2026 |
| 8-K/A | Amended current report | Feb 5, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Acquisition or sale of assets, Results of operations, Regulation FD disclosure
|
Jan 30, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 8, 2026 | Jan 8, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 7, 2026 | — |
| 4 | Insider transaction | Dec 4, 2025 | Dec 2, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 28, 2025 | — |
| 4 | Insider transaction | Nov 26, 2025 | Nov 24, 2025 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 20, 2025 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 20, 2025 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 20, 2025 |
| 4 | Insider transaction | Nov 20, 2025 | Nov 18, 2025 |
| 4 | Insider transaction | Nov 17, 2025 | Nov 13, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Exit or restructuring costs
|
Sep 17, 2025 | Sep 13, 2025 |
| 4 | Insider transaction | Sep 11, 2025 | Sep 9, 2025 |
| 4 | Insider transaction | Sep 5, 2025 | Sep 3, 2025 |
| 8-K |
Current report
Exit or restructuring costs
|
Sep 3, 2025 | Aug 28, 2025 |
| 4 | Insider transaction | Aug 26, 2025 | Aug 22, 2025 |
| 4 | Insider transaction | Aug 22, 2025 | Aug 20, 2025 |
| 4 | Insider transaction | Aug 22, 2025 | Aug 20, 2025 |
| 4 | Insider transaction | Aug 22, 2025 | Aug 20, 2025 |
| 4 | Insider transaction | Aug 15, 2025 | Aug 13, 2025 |
| S-8 | Employee stock plan registration | Aug 15, 2025 | — |
| 10-Q | Quarterly report | Aug 15, 2025 | Jun 30, 2025 |
| NT 10-Q | Filing | Aug 12, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 5, 2025 | Aug 1, 2025 |
| 4 | Insider transaction | Aug 5, 2025 | Aug 1, 2025 |
| 8-K |
Current report
Officer or director change
|
Aug 1, 2025 | Aug 1, 2025 |
| 4/A | Filing | Jul 30, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 24, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 24, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 24, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 24, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 24, 2025 | Jun 20, 2025 |
| 4 | Insider transaction | Jun 24, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 23, 2025 | Jun 22, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 20, 2025 | Jun 18, 2025 |
| SD | Specialized disclosure (conflict minerals) | Jun 2, 2025 | — |
| 4 | Insider transaction | May 30, 2025 | May 28, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 28, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 28, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 22, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 144 | Notice of proposed sale | May 23, 2025 | — |
| 144 | Notice of proposed sale | May 23, 2025 | — |
| 144 | Notice of proposed sale | May 23, 2025 | — |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 144 | Notice of proposed sale | May 22, 2025 | — |
| 144 | Notice of proposed sale | May 22, 2025 | — |
| 144 | Notice of proposed sale | May 22, 2025 | — |
| 144 | Notice of proposed sale | May 21, 2025 | — |
| 144 | Notice of proposed sale | May 21, 2025 | — |
| 144 | Notice of proposed sale | May 21, 2025 | — |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2025 | May 6, 2025 |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Apr 8, 2025 | Apr 4, 2025 |
| 4 | Insider transaction | Apr 8, 2025 | Apr 4, 2025 |
| 4 | Insider transaction | Mar 24, 2025 | Mar 21, 2025 |
| 4 | Insider transaction | Mar 24, 2025 | Mar 21, 2025 |
| 4 | Insider transaction | Mar 24, 2025 | Mar 21, 2025 |
| 10-K | Annual report | Mar 11, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Mar 4, 2025 | Feb 28, 2025 |
| 4/A | Filing | Mar 4, 2025 | Aug 2, 2024 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 4, 2025 | — |
| 4 | Insider transaction | Mar 4, 2025 | Feb 28, 2025 |
| 4 | Insider transaction | Mar 4, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 26, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 24, 2025 | Feb 20, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 10, 2025 | Jan 3, 2025 |
| 8-K | Current report | Dec 20, 2024 | Dec 19, 2024 |
| 4 | Insider transaction | Nov 21, 2024 | Nov 20, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 144 | Notice of proposed sale | Nov 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Nov 7, 2024 | Nov 6, 2024 |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 4, 2024 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 30, 2024 | Oct 30, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 24, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 21, 2024 | — |
| 144 | Notice of proposed sale | Sep 9, 2024 | — |
| 4 | Insider transaction | Sep 5, 2024 | Aug 20, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Aug 20, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 5, 2024 | Sep 5, 2024 |
| 3 | Initial insider ownership | Sep 3, 2024 | Aug 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Aug 30, 2024 | Aug 27, 2024 |
| 4 | Insider transaction | Aug 29, 2024 | Aug 27, 2024 |
| 4 | Insider transaction | Aug 26, 2024 | Aug 22, 2024 |
| 4 | Insider transaction | Aug 21, 2024 | Aug 19, 2024 |
| 4 | Insider transaction | Aug 19, 2024 | Aug 15, 2024 |
| 4 | Insider transaction | Aug 16, 2024 | Aug 14, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 14, 2024 | — |
| 4 | Insider transaction | Aug 13, 2024 | Aug 9, 2024 |
| 4 | Insider transaction | Aug 9, 2024 | Aug 7, 2024 |
| 4 | Insider transaction | Aug 6, 2024 | Aug 2, 2024 |
| S-8 | Employee stock plan registration | Aug 6, 2024 | — |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 31, 2024 | Jul 26, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 31, 2024 | Jul 31, 2024 |
| 4 | Insider transaction | Jul 23, 2024 | Jul 19, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 28, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 28, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 28, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 28, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 28, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jul 1, 2024 | Jun 27, 2024 |
| EFFECT | Filing | Jun 27, 2024 | — |
| 3 | Initial insider ownership | Jun 26, 2024 | Jun 18, 2024 |
| CORRESP | Letter to the SEC | Jun 25, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 25, 2024 | — |
| 144 | Notice of proposed sale | Jun 24, 2024 | — |
| 144 | Notice of proposed sale | Jun 24, 2024 | — |
| 144 | Notice of proposed sale | Jun 24, 2024 | — |
| 4 | Insider transaction | Jun 21, 2024 | Jun 18, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LAB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1162194
- Former names
- FLUIDIGM CORP (until Apr 1, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.